Joanna Z. Peng

Suggest Changes
Learn More
A potent novel compound (MK-3577) was developed for the treatment of type 2 diabetes mellitus (T2DM) through blocking the glucagon receptor. A semi-mechanistic model was developed to describe the(More)
  • 1